| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |